SYM2206 is primarily utilized in research and development within the field of neuroscience, particularly in studies focusing on neurodegenerative diseases. It acts as a selective inhibitor, targeting specific pathways involved in neuronal damage and inflammation. This makes it a valuable tool for investigating potential therapeutic strategies for conditions like Alzheimer's disease, Parkinson's disease, and other disorders characterized by neuronal degeneration. Additionally, SYM2206 is used in preclinical studies to understand the mechanisms of neuroprotection and to evaluate its efficacy in mitigating cognitive decline and motor dysfunction in experimental models. Its application extends to drug discovery, where it serves as a reference compound for developing novel treatments aimed at preserving neuronal health and function.